524470 Stock Overview
Manufactures, markets, and sells pharmaceutical formulation products in India.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Syncom Formulations (India) Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹21.29 |
52 Week High | ₹27.94 |
52 Week Low | ₹9.05 |
Beta | 1.4 |
11 Month Change | 8.79% |
3 Month Change | 35.69% |
1 Year Change | 132.93% |
33 Year Change | 94.25% |
5 Year Change | 2,985.51% |
Change since IPO | 1,316.64% |
Recent News & Updates
Recent updates
Shareholder Returns
524470 | IN Pharmaceuticals | IN Market | |
---|---|---|---|
7D | 7.4% | 1.5% | 0.2% |
1Y | 132.9% | 54.6% | 35.3% |
Return vs Industry: 524470 exceeded the Indian Pharmaceuticals industry which returned 54.6% over the past year.
Return vs Market: 524470 exceeded the Indian Market which returned 35.3% over the past year.
Price Volatility
524470 volatility | |
---|---|
524470 Average Weekly Movement | 10.3% |
Pharmaceuticals Industry Average Movement | 6.2% |
Market Average Movement | 6.2% |
10% most volatile stocks in IN Market | 9.3% |
10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 524470's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 524470's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1988 | 998 | Vijay Bankda | www.syncomformulations.com |
Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India. It operates through Manufacturing and Dealing in Pharmaceutical Drug & Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, gynae, opthal, ortho, and pediatrics formulations.
Syncom Formulations (India) Limited Fundamentals Summary
524470 fundamental statistics | |
---|---|
Market cap | ₹20.01b |
Earnings (TTM) | ₹285.50m |
Revenue (TTM) | ₹2.91b |
70.1x
P/E Ratio6.9x
P/S RatioIs 524470 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
524470 income statement (TTM) | |
---|---|
Revenue | ₹2.91b |
Cost of Revenue | ₹1.76b |
Gross Profit | ₹1.15b |
Other Expenses | ₹864.12m |
Earnings | ₹285.50m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 11, 2024
Earnings per share (EPS) | 0.30 |
Gross Margin | 39.53% |
Net Profit Margin | 9.82% |
Debt/Equity Ratio | 25.2% |
How did 524470 perform over the long term?
See historical performance and comparison